| Literature DB >> 34948073 |
Shihui Liu1, Mary Miyaji2, Osamu Hosoya2, Toshihiko Matsuo1.
Abstract
PURPOSE: NK-5962 is a key component of photoelectric dye-coupled polyethylene film, designated Okayama University type-retinal prosthesis (OUReP™). Previously, we found that NK-5962 solution could reduce the number of apoptotic photoreceptors in the eyes of the Royal College of Surgeons (RCS) rats by intravitreal injection under a 12 h light/dark cycle. This study aimed to explore possible molecular mechanisms underlying the anti-apoptotic effect of NK-5962 in the retina of RCS rats.Entities:
Keywords: PI3K–Akt signaling pathway; SERPINF1; apoptosis; drug; extracellular exosome; extracellular matrix organization; photoreceptors; pigment epithelium-derived factor (PEDF); retina; retinitis pigmentosa
Mesh:
Substances:
Year: 2021 PMID: 34948073 PMCID: PMC8703378 DOI: 10.3390/ijms222413276
Source DB: PubMed Journal: Int J Mol Sci ISSN: 1422-0067 Impact factor: 5.923
Figure 1NK-5962 and experimental design. (A) Chemical structure of NK-5962. (B) NK-5962 solution (8.2 μg/mL). (C) Experimental schedule.
Figure 2The volcano plot shows the distribution of the fold changes of each mRNA transcript in NK-5962-injected eyes versus vehicle-treated eyes. Genes that pass a threshold of log(FC) > 0.585, p value < 0.05 are highlighted by red (up-regulated) and blue (down-regulated), respectively. Only one gene (LYVE1) was commonly down-regulated among samples treated with NK-5962. FC: fold change.
Up-regulated genes in NK-5962-treated retinas.
| Gene Name | Description | Locus | Log2(Fold_Change) | References | ||
|---|---|---|---|---|---|---|
|
| Serpin Family F Member 1 | chr10:62713440-62739444 | 2.722 | 5.00 × 10−5 | 0.012 | [ |
|
| Collagen Type IV Alpha 1 Chain | chr16:83045182-83157835 | 2.651 | 5.00 × 10−5 | 0.012 | [ |
|
| Crystallin Alpha B | chr8:54107289-54111502 | 2.368 | 5.00 × 10−5 | 0.012 | [ |
|
| Collagen Type IV Alpha 2 Chain | chr16:82899293-83045155 | 2.293 | 5.00 × 10−5 | 0.012 | [ |
|
| Heparan Sulfate Proteoglycan 2 | chr5:156226988-156328912 | 2.089 | 5.00 × 10−5 | 0.012 | [ |
|
| Aquaporin 1 | chr4:84098345-84110524 | 2.043 | 5.00 × 10−5 | 0.012 | [ |
|
| Annexin A1 | chr1:223478435-223494455 | 1.798 | 5.00 × 10−5 | 0.012 | [ |
|
| ECRG4 augurin precursor | chr9:42930953-42950605 | 1.575 | 5.00 × 10−5 | 0.012 | [ |
|
| Wnt Ligand Secretion Mediator | chr2:258014377-258128180 | 1.392 | 5.00 × 10−5 | 0.012 | [ |
|
| Solute Carrier Family 22 Member 8 | chr1:211269365-211287596 | 1.388 | 5.00 × 10−5 | 0.012 | [ |
|
| Superoxide dismutase 3 | chr14:63381446-63387180 | 1.328 | 5.00 × 10−5 | 0.012 | [ |
|
| Fibulin 2 | chr4:125380499-125441075 | 1.296 | 5.00 × 10−5 | 0.012 | [ |
|
| Opticin | chr13:46846755-46858100 | 1.292 | 5.00 × 10−5 | 0.012 | [ |
|
| Solute Carrier Family 13 Member 4 | chr4:62679592-62724547 | 1.265 | 5.00 × 10−5 | 0.012 | [ |
|
| Fibroblast Growth Factor Receptor 2 | chr1:189482974-189589279 | 1.243 | 5.00 × 10−5 | 0.012 | [ |
|
| Fibulin 1 | chr7:123208153-123287289 | 1.194 | 5.00 × 10−5 | 0.012 | [ |
|
| Tyrosinase-Related Protein 1 | chr5:99518305-99537289 | 1.190 | 5.00 × 10−5 | 0.012 | [ |
|
| Osteoglycin | chr17:20969065-21145330 | 1.160 | 5.00 × 10−5 | 0.012 | [ |
|
| Gap Junction Protein Alpha 1 | chr20:35409814-35422259 | 1.117 | 5.00 × 10−5 | 0.012 | [ |
|
| WAP Four-Disulfide Core Domain 1 | chr19:49924309-49943113 | 1.116 | 5.00 × 10−5 | 0.012 | [ |
|
| Latent Transforming Growth Factor Beta Binding Protein 2 | chr6:108826438-108924895 | 1.112 | 5.00 × 10−5 | 0.012 | [ |
|
| Collagen Type IV Alpha 5 Chain | chrX:36918650-37130562 | 1.105 | 5.00 × 10−5 | 0.012 | [ |
|
| Death-Associated Protein Like 1 | chr3:41187966-41207910 | 1.070 | 5.00 × 10−5 | 0.012 | [ |
|
| Ectonucleotide Pyrophosphatase/Phosphodiesterase 2 | chr7:91295814-91377947 | 0.997 | 5.00 × 10−5 | 0.012 | [ |
|
| Solute Carrier Family 13 Member 3 | chr3:156447899-156510620 | 0.914 | 5.00 × 10−5 | 0.012 | [ |
|
| Matrix Remodeling Associated 8 | chr5:172698112-172702607 | 0.899 | 5.00 × 10−5 | 0.012 | [ |
|
| Collagen Type IX Alpha 1 Chain | chr9:22907067-22990836 | 0.855 | 5.00 × 10−5 | 0.012 | [ |
|
| Collagen Type VIII Alpha 1 Chain | chr11:43604973-43737050 | 1.879 | 1.50 × 10−4 | 0.029 | [ |
|
| Membrane Frizzled-Related Protein | chr8:47084055-47089218 | 1.169 | 1.50 × 10−4 | 0.029 | [ |
|
| Collagen Type V Alpha 1 Chain | chr3:6825780-6973521 | 0.901 | 1.50 × 10−4 | 0.029 | [ |
|
| Fibrillin 1 | chr3:112607811-112804951 | 0.895 | 1.50 × 10−4 | 0.029 | [ |
|
| Collagen alpha-1(XVIII) chain | chr20:11872458-11982466 | 0.834 | 1.50 × 10−4 | 0.029 | [ |
|
| Solute Carrier Family 6 Member 13 | chr4:157736263-157771945 | 0.942 | 2.00 × 10−4 | 0.036 | [ |
|
| ABI Family Member 3 Binding Protein | chr11:44853363-45072422 | 1.122 | 2.50 × 10−4 | 0.041 | [ |
|
| Carboxypeptidase X, M14 Family Member 1 | chr3:118000979-118007777 | 1.102 | 2.50 × 10−4 | 0.041 | [ |
|
| Fibromodulin | chr13:46987713-46998331 | 0.887 | 2.50 × 10−4 | 0.041 | [ |
|
| Versican | chr2:19712628-19812592 | 0.868 | 4.00 × 10−4 | 0.061 | [ |
|
| Serpin Family H Member 1 | chr1:156666873-156674336 | 0.765 | 4.00 × 10−4 | 0.061 | [ |
|
| Procollagen C-Endopeptidase Enhancer | chr12:19672504-19690374 | 1.398 | 4.50 × 10−4 | 0.068 | [ |
|
| Solute Carrier Family 26 Member | chr6:49389211-49427000 | 0.835 | 5.50 × 10−4 | 0.078 | [ |
|
| Follistatin Like 1 | chr11:64680819-64735683 | 0.694 | 5.50 × 10−4 | 0.078 | [ |
|
| Olfactomedin Like 2A | chr3:18731164-18751940 | 0.713 | 6.50 × 10−4 | 0.089 | [ |
|
| Mannose Receptor C Type 2 | chr10:94689060-94753073 | 0.831 | 9.00 × 10−4 | 0.117 | [ |
|
| Glutathione S-Transferase Mu 2 | chr2:203549021-203553380 | 1.207 | 9.50 × 10−4 | 0.120 | [ |
|
| Collagen Type VI Alpha 2 Chain | chr20:12436782-12464512 | 0.859 | 1.05 × 10−3 | 0.127 | [ |
|
| Collagen Type IX Alpha 2 Chain | chr5:141623364-141640224 | 0.770 | 1.15 × 10−3 | 0.137 | [ |
|
| nidogen-2 | chr15:4801182-4856895 | 0.769 | 1.40 × 10−3 | 0.163 | [ |
|
| Coagulation Factor V | chr13:79934955-79997282 | 0.745 | 1.50 × 10−3 | 0.171 | [ |
|
| Sushi, Nidogen, and EGF-Like Domains 1 | chr9:92509498-92568597 | 0.672 | 1.65 × 10−3 | 0.181 | [ |
|
| Collectin Subfamily Member 12 | chr18:996296-1188288 | 0.951 | 1.80 × 10−3 | 0.192 | [ |
|
| Collagen Type I Alpha 2 Chain | chr4:29393502-29429101 | 1.066 | 2.60 × 10−3 | 0.264 | [ |
|
| Solute Carrier Family 16 Member 12 | chr1:238643039-238665699 | 0.962 | 2.85 × 10−3 | 0.281 | [ |
|
| Claudin 19 | chr5:139838013-139842711 | 0.896 | 5.80 × 10−3 | 0.480 | [ |
|
| Myosin VC | chr8:80042255-80118773 | 0.921 | 5.85 × 10−3 | 0.481 | [ |
|
| Premelanosome Protein | chr7:2007881-2045336 | 1.294 | 1.40 × 10−2 | 0.941 | [ |
Down-regulated genes in NK-5962-treated retinas.
| Gene Name | Description | Locus | Log2(Fold_Change) | Reference | ||
|---|---|---|---|---|---|---|
|
| Lymphatic Vessel Endothelial Hyaluronan Receptor 1 | chr1:168601459-168622234 | −1.001 | 1.58 × 10−2 | 0.999 | [ |
Figure 3The enrichment analysis of 55 significant up-regulated genes was performed by Metascape. (A) Metascape bar graph for viewing the top enriched clusters, where each cluster uses a discrete color to indicate statistical significance. (B) Metascape visualization of the interactome network formed by all 55 genes from the Table 1, where the MCODE compounds are colored according to their identities. The most interesting enriched terms in the category were extracellular matrix organization (red box).
Top Reactome pathways significantly enriched in DEGs related to anti-apoptosis in NK-5962-treated retinas (Metascape).
| Category | Term | Description | LogP | InTerm_ | Genes |
|---|---|---|---|---|---|
| Reactome Gene Sets | R-RNO- | Extracellular matrix organization | −18.264 | 16/198 |
Top enriched GO terms significantly enriched in DEGs related to anti-apoptosis in NK-5962-treated retinas (Metascape).
| Category | Term | Description | LogP | InTerm_ | Genes |
|---|---|---|---|---|---|
| GO Biological Processes | GO:0030198 | extracellular matrix | −16.615 | 17/308 | |
| GO Biological Processes | GO:0043062 | extracellular structure | −16.591 | 17/309 | |
| GO Biological Processes | GO:0045229 | external | −16.567 | 17/310 |
Top KEGG pathways significantly enriched in DEGs related to anti-apoptosis in NK-5962-treated retinas (Metascape).
| Category | Term | Description | LogP | InTerm_InList | Genes |
|---|---|---|---|---|---|
| KEGG Pathway | ko04512, | ECM-receptor | −9.901 | 8/81 | |
| KEGG Pathway | ko04151, | −5.166 | 8/329 |
Figure 4Enrichment analysis of top 55 up-regulated genes based on DAVID bioinformation resources. (A) Bubble plot of the enriched GO terms: cellular component terms (CC), molecular function terms (MF), biological process terms (BP). The first three pathways with the most genes (smaller p value), and which may be related to protection of photoreceptor cells are as follows: extracellular exosome, extracellular space, and extracellular matrix (red box). (B) Bubble plot of the enriched KEGG pathways. The pathways which may be related to protection of photoreceptor cells are as follows: PI3K–Akt signaling pathway. In addition, there are PI3K–Akt signaling pathway-related pathways: focal adhesion, ECM-receptor interaction (according to the map of PI3K–Akt signaling pathway, https://www.genome.jp/kegg-bin/show_pathway?rno04151 (accessed on 18 June 2021). The colors of the nodes are illustrated from red to green in descending order of –log10 (p value). X-axis: signaling pathway or function; Y-axis: percentage of the number of DEGs assigned to a term among the total number of DEGs annotated in the network; Bubble size: number of DEGs assigned to a pathway or function; Color: enriched p value.
Top three GO terms significantly enriched in DEGs related to anti-apoptosis in NK-5962-treated retinas (DAVID).
| Category | Term | Count | % | Genes | |
|---|---|---|---|---|---|
| GOTERM_ | GO:0070062~ | 31 | 56.3 | 8.19 × 10−13 | |
| GOTERM_ | GO:0005615~ | 22 | 40.0 | 2.30 × 10−11 | |
| GOTERM_ | GO:0031012~ | 21 | 38.1 | 3.45 × 10−24 |
Top three KEGG pathways significantly enriched in DEGs related to anti-apoptosis in NK-5962-treated retinas (DAVID).
| Category | Term | Count | % | Genes | |
|---|---|---|---|---|---|
| KEGG_PATHWAY | rno04151: | 7 | 12.7 | 2.76 × 10−4 | |
| KEGG_PATHWAY | rno04512:ECM- | 6 | 10.9 | 4.03 × 10−6 | |
| KEGG_PATHWAY | rno04510:Focal | 6 | 10.9 | 2.52 × 10−4 |